I was looking at this page – SARS-CoV-2 Coronavirus and patents – on the ABG (European IP firm) firm site.
It mentions Gilead Sciences. This got me interested in GILD’s current stock price. $70.11
…Gilead Sciences, a US biopharmaceutical company that holds several patents and patent applications for potential treatments of coronavirus infections. For example, the international patent application WO 2017/049060 A1, on behalf of this company, contains claims generically addressed to the use of remdesivir in infections caused by viruses of the Coronaviridae family, to which coronaviruses belong
1 year window. Jan 2020 around $65, to a peak of $81.